Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.
The three-drug combination cured most people who had experienced previous treatment failure.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.
Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.
A quick overview of our reporting on the 53rd International Liver Congress in Vienna
What’s more, such treatment is linked to remission of non–Hodgkin lymphoma.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.
Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.